Clinical Trial Update: Cardiac Safety of Indacaterol [Phase 1]

View source ↗

Summary

A Phase 1 trial update reports on the cardiac safety of indacaterol, completed in healthy volunteers and patients with chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol (indacaterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Healthy Volunteers, Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED